These results indicated that the overall expression level of TYRO3 in breast cancer cells is highly patient specific, while the high-TYRO3 expressing samples always had TYRO3 preferably express in a small group of actively dividing cells. This evidence concerns the gene TYRO3 and breast carcinoma.